News & Insights

Predictive Analytics in the Public Health Arena

Millions of series of zeros and ones are behind everything we do as scientific research and healthcare professionals. We’re able to process this data through dozens of different lenses, but what gets us truly excited is the growing ability to use predictive analytics to improve population health. Venebio’s focus in predictive analytics has typically aligned […]

Venebio presents at ISPOR 2017

Recent legislative changes such as the Patient Protection and Affordable Care Act, HITECH, and the Medicare Access and CHIP Reauthorization Act are forcing the health care industry to find ways to improve quality and outcomes while lowering costs. Information technology and predictive analytics are being explored to identify viable, “cost-neutral” solutions to help achieve those […]

Recipe for the perfect meta-analysis

So, you’ve conducted a systematic review of the evidence on your topic, and you’re not sure whether you can—or should—combine the data quantitatively. It’s a common question, and there’s no “right” answer. However, the following considerations can help guide you toward the best decision. How many studies? One of the most frequently asked questions in […]

Venebio Launches Tool to Help Reduce Opioid Overdoses: Initial adopters of Venebio Opioid Advisor include health plans and Medicaid-managed care plans in Virginia and New York

RICHMOND, Va. (July 12, 2017) – Venebio Group, a leader in personalized risk prediction algorithms, today announced that its risk-screening tool for opioid overdose, Venebio Opioid Advisor™ (VOA™), is now commercially available nationwide following the conclusion of its pilot phase. While much of the national attention around the opioid epidemic has focused on addiction, many […]

Study of U.S. Opioid Users Shows Venebio’s Overdose Risk Index to Have 90% Accuracy

Richmond, Va. – April 13, 2017 – A recent study published in Pain Medicine validates the strong performance of Venebio Group’s risk index tool — Venebio Opioid Advisor (VOA) — at predicting the likelihood of a life-threatening overdose in patients taking a prescription opioid. Prescription opioid sales quadrupled in the United States between 1999 and […]

New Study Reveals Highest Risk Profiles for Opioid Overdose

Richmond, Va. – April 13, 2017 – Individuals suffering from a substance use disorder (SUD) or depression are among those at highest risk for a serious prescription opioid overdose, according to a study published in Pain Medicine. The retrospective, case-control study analyzed and compared patients with an opioid prescription from two health care claims databases: […]

Venebio receives $1.5 million NIH grant for Venebio Opioid Advisor

RICHMOND, Virginia, December 1, 2016 – Venebio Group LLC, a Richmond, Virginia based life sciences research consultancy, has been awarded a research grant from the National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH). The $1.5 million grant is a Direct-to- Phase-II Small Business Innovation Research (SBIR) Grant and is aimed […]

Venebio featured on the cover of the Richmond Times-Dispatch Metro Business Section

RICHMOND, Virginia, October 31, 2016 – Venebio Group, LLC, was featured on the cover of the Richmond Times-Dispatch Metro Business Section. The accompanying article highlights the recent $1.5 million NIH grant for continual development of the Venebio Opioid Advisor. Click here to read the full article online, or download a PDF version.  

Venebio releases Fact Sheet for Venebio Opioid Advisor

RICHMOND, Virginia, February 8, 2016 – Venebio Group, LLC, has published a Fact Sheet for their algorithm-based clinical decision support tool, Venebio Opioid Advisor.  

Venebio subsidiary, algorithmRx, receives second year of two-year NIH grant

RICHMOND, Virginia, May 20, 2015 – algorithmRx, headquartered in Richmond, Virginia, announced today that it has received confirmation of funding for the second year of a research grant from the National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH) as part of the NIH’s Small Business Innovation Research (SBIR) program. […]